Revive Therapeutics Ltd：エムダメン

SEDAR10/29 08:19

Revive Therapeutics Ltd：監査済み年次財務諸表 EN

SEDAR10/29 06:42

Revive Therapeutics Provides Update on Psilocybin Clinical Study for Methamphetamine Use Disorder

MT Newswires04/02 20:31

Revive Therapeutics Submits Type C Meeting Request Package to FDA for Clinical Study of Bucillami...

Stockhouse 03/27 21:08

Revive Therapeutics to Submit Type C Meeting Request With FDA for Bucillamine to Treat Long COVID

MT Newswires03/19 20:26

Revive Therapeutics To Submit Type C Meeting Request With FDA for Bucillamine to Treat Long COVID

Stockhouse 03/19 19:00